Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HULAND, Hartwig")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 180

  • Page / 8
Export

Selection :

  • and

Open retropubic nerve-sparing radical prostatectomyGRAEFEN, Markus; WALZ, Jochen; HULAND, Hartwig et al.European urology. 2006, Vol 49, Num 1, pp 38-48, issn 0302-2838, 11 p.Article

Improving Outcome of Surgical Procedures Is Not Possible Without Adequate Quality MeasurementSCHLOMM, Thorsten; HULAND, Hartwig; GRAEFEN, Markus et al.European urology. 2014, Vol 65, Num 6, pp 1017-1019, issn 0302-2838, 3 p.Article

Basic principles of anatomy for optimal surgical treatment of prostate cancer : Treatment of localized prostate cancerWALZ, Jochen; GRAEFEN, Markus; HULAND, Hartwig et al.World journal of urology (Print). 2007, Vol 25, Num 1, pp 31-38, issn 0724-4983, 8 p.Article

Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancerHEINZER, Hans; HULAND, Edith; HULAND, Hartwig et al.World journal of urology (Print). 2001, Vol 19, Num 2, pp 111-119, issn 0724-4983Article

Major postoperative complications secondary to use of the bookwalter self-retaining retractorNOLDUS, Joachim; GRAEFEN, Markus; HULAND, Hartwig et al.Urology (Ridgewood, NJ). 2002, Vol 60, Num 6, pp 964-967, issn 0090-4295, 4 p.Article

Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma: Impact on changing treatment modalitiesHAESE, Alexander; EPSTEIN, Jonathan I; HULAND, Hartwig et al.Cancer. 2002, Vol 95, Num 5, pp 1016-1021, issn 0008-543XArticle

Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumpsHAUTMANN, Stefan; HULAND, Edith; WULLBRAND, Andreas et al.Anticancer research. 2000, Vol 20, Num 6B, pp 4495-4498, issn 0250-7005Article

Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomySTEUBER, Thomas; ERBERSDOBLER, Andreas; GRAEFEN, Markus et al.Cancer. 2006, Vol 106, Num 4, pp 775-782, issn 0008-543X, 8 p.Article

Intraoperative and perioperative morbidity of contemporary Radical retropubic prostatectomy in a consecutive series of 1243 patients: Results of a single center between 1999 and 2002AUGUSTIN, Herbert; HAMMERER, Peter; GRAEFEN, Markus et al.European urology. 2003, Vol 43, Num 2, pp 113-118, issn 0302-2838, 6 p.Article

Prostate cancers in the transition zone: Part 2; clinical aspectsAUGUSTIN, Herbert; ERBERSDOBLER, Andreas; HAMMERER, Peter G et al.BJU international (Papier). 2004, Vol 94, Num 9, pp 1226-1229, issn 1464-4096, 4 p.Article

Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zonesAUGUSTIN, Herbert; ERBERSDOBLER, Andreas; GRAEFEN, Markus et al.The Prostate. 2003, Vol 55, Num 1, pp 48-54, issn 0270-4137, 7 p.Article

Urinary concentration and tissue messenger rna expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstructionSTEPHAN, Miriam; CONRAD, Stefan; EGGERT, Thilo et al.The Journal of urology. 2002, Vol 167, Num 3, pp 1497-1502, issn 0022-5347Article

The expression of angiopoietins and their receptor Tie-2 in human prostate carcinomaWURMBACH, Jan-Henner; HAMMERER, Peter; SEVINC, Sema et al.Anticancer research. 2000, Vol 20, Num 6D, pp 5217-5220, issn 0250-7005Article

Patient-reported sexual function after nerve-sparing radical retropubic prostatectomyNOLDUS, Joachim; MICHL, Uwe; GRAEFEN, Markus et al.European urology. 2002, Vol 42, Num 2, pp 118-124, issn 0302-2838Article

Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patientsSCHWARZENBACH, Heidi; CHUN, Felix K.-H; ISBARN, Hendrik et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 5, pp 811-819, issn 0171-5216, 9 p.Article

Role of nomograms for prostate cancer in 2007CHUN, Felix K.-H; KARAKIEWICZ, Pierre I; HULAND, Hartwig et al.World journal of urology (Print). 2007, Vol 25, Num 2, pp 131-142, issn 0724-4983, 12 p.Article

Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failurePALISAAR, Rein-Jüri; NOLDUS, Joachim; GRAEFEN, Markus et al.European urology. 2005, Vol 47, Num 2, pp 176-184, issn 0302-2838, 9 p.Article

Reasonable delay of surgical treatment in men with localized prostate cancer - : Impact on prognosis?GRAEFEN, Markus; WALZ, Jochen; CHUN, K.-H. F et al.European urology. 2005, Vol 47, Num 6, pp 756-760, issn 0302-2838, 5 p.Article

Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with bacillus calmette-guérin (BCG) in patients with non-muscle-invasive bladder carcinoma. CommentaryFRIEDRICH, Martin G; PICHLMEIER, Uwe; SCHWAIBOLD, Hartwig et al.European urology. 2007, Vol 52, Num 4, pp 1123-1130, issn 0302-2838, 8 p.Article

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancerTOMA, Marieta I; FRIEDRICH, Martin G; HAUTMANN, Stefan H et al.World journal of urology (Print). 2004, Vol 22, Num 2, pp 145-149, issn 0724-4983, 5 p.Article

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence? CommentaryFRIEDRICH, Martin G; HELLSTERN, Angelika; TOMA, Marieta I et al.European urology. 2003, Vol 43, Num 2, pp 146-151, issn 0302-2838, 6 p.Article

Zonal location of prostate cancer: Significance for disease-free survival after radical prostatectomy?AUGUSTIN, Herbert; HAMMERER, Peter G; BLONSKI, Jakob et al.Urology (Ridgewood, NJ). 2003, Vol 62, Num 1, pp 79-85, issn 0090-4295, 7 p.Article

Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomyAUGUSTIN, Herbert; HAMMERER, Peter G; GRAEFEN, Markus et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 11, pp 662-668, issn 0171-5216, 7 p.Article

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigenSTEUBER, Thomas; NURMIKKO, Pauliina; HAESE, Alexander et al.The Journal of urology. 2002, Vol 168, Num 5, pp 1917-1922, issn 0022-5347Article

Advances in the management of high-risk localised and metastatic prostate cancerBELLMUNT, Joaquim; ATTARD, Gerhardt; BAHL, Amit et al.BJU international. Supplement (Print). 2012, Vol 109, Num 2, pp 8-13, issn 1465-5101, 6 p.Conference Paper

  • Page / 8